John H. Leamon
Chief Tech/Sci/R&D Officer chez ISOPLEXIS CORPORATION
Profil
John H.
Leamon is currently the Senior VP-Research & Development Integration at IsoPlexis Corp.
Previously, he worked as the Vice President-Biology at Cyvek, Inc. from 2012 to 2014.
He received his undergraduate degree from Connecticut College and his graduate and doctorate degrees from the University of Connecticut.
Postes actifs de John H. Leamon
| Sociétés | Poste | Début |
|---|---|---|
| ISOPLEXIS CORPORATION | Chief Tech/Sci/R&D Officer | 01/03/2021 |
Anciens postes connus de John H. Leamon
| Sociétés | Poste | Fin |
|---|---|---|
CyVek, Inc.
 CyVek, Inc. BiotechnologyHealth Technology CyVek, Inc. engages in the development of a novel, platform technology for measuring analytes in biological samples. It is a biotechnology company dedicated to the advancement of healthcare by empowering researchers and clinicians with a disruptive technology for performing multi-analyte immunoassays. The firm is a versatile platform that can be quickly and easily configured for diverse applications such as rapid diagnostic tests, multi-sample multi-analyte tests, or routine ELISA-like tests, for use in both research and clinical settings. The company offers an breadth of applications, from life science research to drug discovery, personalized medicine, diagnostics, and point-of-care testing. CyVek was founded by Per J. Hellsund, Rajiv Pandey and Marty Andrew Putnam in 2010 and is headquartered in Wallingford, CT. | Corporate Officer/Principal | 01/11/2014 |
Formation de John H. Leamon
| Connecticut College | Undergraduate Degree |
| University of Connecticut | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
CyVek, Inc.
CyVek, Inc. BiotechnologyHealth Technology CyVek, Inc. engages in the development of a novel, platform technology for measuring analytes in biological samples. It is a biotechnology company dedicated to the advancement of healthcare by empowering researchers and clinicians with a disruptive technology for performing multi-analyte immunoassays. The firm is a versatile platform that can be quickly and easily configured for diverse applications such as rapid diagnostic tests, multi-sample multi-analyte tests, or routine ELISA-like tests, for use in both research and clinical settings. The company offers an breadth of applications, from life science research to drug discovery, personalized medicine, diagnostics, and point-of-care testing. CyVek was founded by Per J. Hellsund, Rajiv Pandey and Marty Andrew Putnam in 2010 and is headquartered in Wallingford, CT. | Health Technology |
IsoPlexis Corp.
 IsoPlexis Corp. Packaged SoftwareTechnology Services IsoPlexis Corp. engages in the development of curative medicines and personalized therapeutics. Its single cell proteomics platform, which includes instruments, chip consumables and software, provides an end-to-end solution to reveal a more complete view of protein function at an individual cellular level. The company was founded by Sean Mackay, Rong Fan, and Kara K. Brower in March 2013 and is headquartered in Branford, CT. | Technology Services |
